Melatonin, experimental basis for a possible application in breast cancer prevention and treatment - PubMed (original) (raw)
Review
Melatonin, experimental basis for a possible application in breast cancer prevention and treatment
S Cos et al. Histol Histopathol. 2000 Apr.
Abstract
The role of the pineal as an oncostatic gland has been studied in animal models of tumorigenesis, especially on those concerning the mammary gland. The general conclusion is that experimental manipulations activating pineal gland, or the administration of melatonin, reduce the incidence and growth rate of chemically-induced murine mammary tumors, while pinealectomy or situations which implicate a reduction of melatonin production usually stimulate mammary carcinogenesis. The direct actions of melatonin on mammary tumors have been suggested because of its ability to inhibit, at physiological doses (1nM), the in vitro proliferation of MCF-7 human breast cancer cells. In this article we review the outstanding findings related to melatonin actions on mammary which, taken together, support a possible usefulness of this indoleamine in the prevention and treatment of mammary gland malignancy.
Similar articles
- Melatonin and mammary pathological growth.
Cos S, Sánchez-Barceló EJ. Cos S, et al. Front Neuroendocrinol. 2000 Apr;21(2):133-70. doi: 10.1006/frne.1999.0194. Front Neuroendocrinol. 2000. PMID: 10764528 Review. - Melatonin and mammary cancer: a short review.
Sánchez-Barceló EJ, Cos S, Fernández R, Mediavilla MD. Sánchez-Barceló EJ, et al. Endocr Relat Cancer. 2003 Jun;10(2):153-9. doi: 10.1677/erc.0.0100153. Endocr Relat Cancer. 2003. PMID: 12790777 Review. - Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos S, Fernández R, Güézmes A, Sánchez-Barceló EJ. Cos S, et al. Cancer Res. 1998 Oct 1;58(19):4383-90. Cancer Res. 1998. PMID: 9766668 - Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S, González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ. Cos S, et al. Cancer Detect Prev. 2006;30(2):118-28. doi: 10.1016/j.cdp.2006.03.002. Epub 2006 May 2. Cancer Detect Prev. 2006. PMID: 16647824 Review. - Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.
Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, Reiter RJ. Sanchez-Barcelo EJ, et al. Expert Opin Investig Drugs. 2012 Jun;21(6):819-31. doi: 10.1517/13543784.2012.681045. Epub 2012 Apr 16. Expert Opin Investig Drugs. 2012. PMID: 22500582 Review.
Cited by
- Melatonin: A Molecule for Reducing Breast Cancer Risk.
González-González A, Mediavilla MD, Sánchez-Barceló EJ. González-González A, et al. Molecules. 2018 Feb 6;23(2):336. doi: 10.3390/molecules23020336. Molecules. 2018. PMID: 29415446 Free PMC article. Review. - Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Lo Sardo F, Muti P, Blandino G, Strano S. Lo Sardo F, et al. Int J Mol Sci. 2017 Sep 6;18(9):1913. doi: 10.3390/ijms18091913. Int J Mol Sci. 2017. PMID: 28878191 Free PMC article. - Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action.
Posadzki PP, Bajpai R, Kyaw BM, Roberts NJ, Brzezinski A, Christopoulos GI, Divakar U, Bajpai S, Soljak M, Dunleavy G, Jarbrink K, Nang EEK, Soh CK, Car J. Posadzki PP, et al. BMC Med. 2018 Feb 5;16(1):18. doi: 10.1186/s12916-017-1000-8. BMC Med. 2018. PMID: 29397794 Free PMC article. - Melatonin: bone metabolism in oral cavity.
López-Martínez F, Olivares Ponce PN, Guerra Rodríguez M, Martínez Pedraza R. López-Martínez F, et al. Int J Dent. 2012;2012:628406. doi: 10.1155/2012/628406. Epub 2012 Aug 9. Int J Dent. 2012. PMID: 22927853 Free PMC article. - Urinary melatonin levels and skin malignancy.
Ghaderi R, Sehatbakhsh S, Bakhshaee M, Sharifzadeh GR. Ghaderi R, et al. Iran J Med Sci. 2014 Jan;39(1):64-7. Iran J Med Sci. 2014. PMID: 24453396 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical